10:22 AM EDT, 08/06/2024 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) shares were up 6.1% in recent Tuesday trading after the company reported its Q2 results that surpassed market expectations and raised its full-year guidance.

The company reported Q2 adjusted earnings Tuesday of $1.02 per diluted share, down from $1.28 a year earlier.

Analysts polled by Capital IQ expected $0.95.

Net revenue for the quarter ended June 30 was $138 million, up from $116.5 million a year earlier.

Analysts surveyed by Capital IQ expected $129.1 million.

The pharmaceutical company said it now expects full-year 2024 adjusted earnings of $4.38 to $4.82 per diluted share, compared with $4.26 to $4.67 previously. Three analysts polled by Capital IQ expect $4.54.

Net revenue for the year is now expected to be between $540 million to $560 million, compared with its prior outlook of $520 million to $542 million. Three analysts surveyed by Capital IQ expect $542.7 million

Price: 62.78, Change: +3.62, Percent Change: +6.12